Curis Inc

NASDAQ:CRIS

1.81

+0.06 (+3.43%)

4:05:25 PM EDT: $1.78 -0.03 (-1.66%)

Market Cap (Intraday)	19.59M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$2.64 Million
Adjusted EPS	-$1.36

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Curis Inc Stock, NASDAQ:CRIS

Building C, 128 Spring Street, Lexington, Massachusetts 02421

United States of America

Phone: +1.617.503.6500

Number of Employees: 49

http://www.curis.com

Description

Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170 and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes. The CA-170 pipeline is an also an orally-available small molecule antagonist of PD-L1 and VISTA immune checkpoints. The company was founded on February 14, 2000 and is headquartered in Lexington, MA.